drugset / Trial / NCT07060794

Tafenoquine and ACTs (TADORE- Plus)

NCT07060794

Phase 4 Not yet recruiting 507 enrolled Menzies School of Health Research
RandomizedParallel-groupOpen-labelTreatment

Summary

A trial designed to determine whether there is a clinically significant drug-drug interaction of tafenoquine with DHA-piperaquine or artesunate-pyronaridine using a control arm with radical cure given at the end of follow up (delayed radical cure).

Timeline

Start
2026-06
Primary completion
2028-06
Completion
2028-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DHA-piperaquine Unknown
Subject Tafenoquine Small molecule
Subject pyronaridine-artesunate Other / unclassified